Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million

from Moneycontrol Business News https://ift.tt/3BWpqWx

No comments:

Post a Comment

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...